Camoteskimab
Based on 1 publication(s) in Google Scholar
Camoteskimab is a fully human monoclonal antibody with high affinity targeting IL-18. Camoteskimab is applicable to the research of autoinflammatory diseases.
For research use only. We do not sell to patients.
- Purity: 98.56%
- CAS No.: 2492472-82-7
- Molecular Weight:146.34 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Camoteskimab
More
Biological Activity
Description
Isotype
Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
|
IL-18 |
In Vitro
Camoteskimab potently neutralizes the activity of IL-18 in PBMC-based in vitro assays, with an IC50 in the sub-nanomolar range, and inhibits the formation of the IL-18/Ra/RB active complex[3].
Camoteskimab binds to human IL-18 with high affinity at 63 pM[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Human IgG1 kappa
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
-
Flow cytometric analysis of 1X106 A431 cells with Camoteskimab (HY-P99491, red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Fluor 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
Chemical Information
-
CAS No. 2492472-82-7
-
Appearance Liquid
-
Molecular Weight 146.34 kDa
-
Color Colorless to light yellow
-
SMILES
[Camoteskimab]
-
Synonyms
AVTX-007; CERC-007; MEDI 2338
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Phytomedicine
Eupafolin hinders cross-talk between gastric cancer cells and cancer-associated fibroblasts by abrogating the IL18/IL18RAP signaling axis. [Abstract]2024 Nov:134:155984. PMID: 39265444
Purity & Documentation
-
Data Sheet (260 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
[1]. Bindoli S, et al. Adult-Onset Still's Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options. Drugs. 2024;84(3):257-274. [Content Brief]
[2]. Chen X, et al. Identification of cross-talk pathways and PANoptosis-related genes in periodontitis and Alzheimer's disease by bioinformatics analysis and machine learning. Front Aging Neurosci. 2024 Aug 27;16:1430290. [Content Brief]
[4]. Galozzi P, et al. Progress in Biological Therapies for Adult-Onset Still's Disease. Biologics. 2022;16:21-34. Published 2022 Apr 21. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)